-
-
-
-
-
-
-
PTC Therapeutics prices $500M convertible notes at 0% to refinance 2026 debt
-
-
-
-
-
-
-
PTC Therapeutics reports positive results for Huntington's drug votoplam
-
-
-
-
-
-
-
PTC Therapeutics (PTCT) PT Lowered to $200 at Rosenblatt
-
-
-
-
-
-
-
Sandisk to Join S&P 500; Upwork, First Interstate BancSystem, PTC Therapeutics to Join S&P SmallCap 600
-
-
-
-
-
-
-
PTC Therapeutics (PTCT) PT Raised to $87 at BofA Securities
-
-
-
-
-
-
-
FDA rejects PTC Therapeutics' vatiquinone for Friedreich's ataxia
-
-
-
-
-
-
-
PTC Therapeutics (PTCT) PT Raised to $86 at Truist Securities
-
456,626 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

